LB Pharmaceuticals: Funding, Investors & Team (Sep 2026)
LB Pharmaceuticals is a company in the early stages of development in the field of life sciences. They are committed to bringing innovative and enhanced versions of successful treatments for central nervous system disorders to the United States market. These treatments have been widely used in other countries but have never been developed, approved, or introduced in the US. LB Pharmaceuticals aims to establish a research-oriented entity focused on creating new intellectual property related to improving these previously successful medications.
LB Pharmaceuticals has raised $215M across 3 funding rounds on record, the most recent an undisclosed round of $100M announced in Feb 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
LB Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Feb 2026.
LB Pharmaceuticals Funding Rounds
LB Pharmaceuticals raised $40.0M in an undisclosed round announced in Sep 2023.
4 months later, a Series C of $75.0M was announced in Jan 2024.
2.1 years later, an undisclosed round of $100M was announced in Feb 2026.
LB Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
LB Pharmaceuticals Funding Compared to Other Biotechnology Startups
LB Pharmaceuticals' latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like LB Pharmaceuticals in Biotechnology and New York
Companies Similar to LB Pharmaceuticals
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
LB Pharmaceuticals Funding FAQs
What does LB Pharmaceuticals do?
LB Pharmaceuticals is a company in the early stages of development in the field of life sciences. They are committed to bringing innovative and enhanced versions of successful treatments for central nervous system disorders to the United States market. These treatments have been widely used in other countries but have never been developed, approved, or introduced in the US. LB Pharmaceuticals aims to establish a research-oriented entity focused on creating new intellectual property related to improving these previously successful medications.
How much funding has LB Pharmaceuticals raised?
LB Pharmaceuticals has raised $215M across 3 rounds on record. The most recent is an undisclosed round of $100M announced in Feb 2026.
When did LB Pharmaceuticals last raise funding?
LB Pharmaceuticals' most recent funding round on record is an undisclosed round of $100M, announced in Feb 2026.
Who founded LB Pharmaceuticals?
FundedIQ lists Zachary Prensky (Founder) at LB Pharmaceuticals.
Where is LB Pharmaceuticals headquartered?
LB Pharmaceuticals is based in New York, United States.
How many employees does LB Pharmaceuticals have?
LB Pharmaceuticals is in the 11-50 employee band.
How does LB Pharmaceuticals' funding compare to other Biotechnology startups?
LB Pharmaceuticals' latest round of $100M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's LB Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for LB Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.